| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5927143 | American Heart Journal | 2011 | 6 Pages |
Abstract
The addition of tolvaptan to standard therapy for AHFS improves physician-assessed signs and symptoms during hospitalization without serious adverse short- or long-term effects.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Peter S. MD, Mihai MD, Jamil MD, Karl MD, Sadiya MD, Aldo P. MD, Liliana MD, Faiez MD, John C. MD, John PhD, James E. MD, Marvin A. MD,